1. Sturgeon KM, Deng L, Bluethmann SM, Zhou S, Trifiletti DM, Jiang C, Kelly SP, Zaorsky NG. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J. 2019;40:3889– 3897. DOI: 10.1093/eurheartj/ehz766.
2. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, Correa C, Cutter D, Gagliardi G, Gigante B, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987–998. DOI: 10.1056/NEJMoa1209825.
3. Scott AS, Parr LA, Johnstone PA. Risk of cerebrovascular events after neck and supraclavicular radiotherapy: a systematic review. Radiother Oncol. 2009;90:163–165. DOI: 10.1016/j.radonc.2008.12.019.
4. Plummer C, Henderson RD, O’Sullivan JD, Read SJ. Ischemic stroke and transient ischemic attack after head and neck radiotherapy: a review. Stroke. 2011;42:2410–2418. DOI: 10.1161/STROKEAHA.111.615203.
5. Liao W, Zheng Y, Bi S, Zhang B, Xiong Y, Li YI, Fang W, Xiao S, Yang L, Thea A, et al. Carotid stenosis prevalence after radiotherapy in nasopharyngeal carcinoma: a meta-analysis. Radiother Oncol. 2019;133:167– 175. DOI: 10.1016/j.radonc.2018.11.013.
6. Childs BG, Durik M, Baker DJ, van Deursen JM. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med. 2015;21:1424–1435. DOI: 10.1038/nm.4000.
7. Rodier F, Coppé JP, Patil CK, Hoeijmakers WA, Muñoz DP, Raza SR, Freund A, Campeau E, Davalos AR, Campisi J. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol. 2009;11:973–979. DOI: 10.1038/ ncb1909.
8. Rodier F, Muñoz DP, Teachenor R, Chu V, Le O, Bhaumik D, Coppé J-P, Campeau E, Beauséjour CM, Kim S-H, et al. DNA-scars: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J Cell Sci. 2011;124:68–81. DOI: 10.1242/jcs.071340.
9. Aratani S, Tagawa M, Nagasaka S, Sakai Y, Shimizu A, Tsuruoka S. Radiation-induced premature cellular senescence involved in glomerular diseases in rats. Sci Rep. 2018;8:16812. DOI: 10.1038/s41598-018- 34893-8.
10. Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation. 2002;106:927–932. DOI: 10.1161/01.CIR.0000026393.47805.21.
11. Childs BG, Baker DJ, Wijshake T, Conover CA, Campisi J, van Deursen JM. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science. 2016;354:472–477. DOI: 10.1126/science.aaf6659.
12. Nam D, Ni CW, Rezvan A, Suo J, Budzyn K, Llanos A, Harrison D, Giddens D, Jo H. Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis. Am J Physiol Heart Circ Physiol. 2009;297:H1535–H1543. DOI: 10.1152/ajpheart.00510.2009.
13. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262–1275. DOI: 10.1161/01.ATV.20.5.1262.
14. Tian Y, Kelemen SE, Autieri MV. Inhibition of AIF-1 expression by constitutive siRNA expression reduces macrophage migration, proliferation, and signal transduction initiated by atherogenic stimuli. Am J Physiol Cell Physiol. 2006;290:C1083–C1091. DOI: 10.1152/ajpce ll.00381.2005.
15. Worth NF, Rolfe BE, Song J, Campbell GR. Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteins. Cell Motil Cytoskeleton. 2001;49:130–145. DOI: 10.1002/cm.1027.
16. Kuo LJ, Yang LX. Gamma-H2AX—a novel biomarker for DNA doublestrand breaks. In Vivo. 2008;22:305–309.
17. Anderson L, Henderson C, Adachi Y. Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage. Mol Cell Biol. 2001;21:1719–1729. DOI: 10.1128/MCB.21.5.1719-1729.2001.
18. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA. 1996;93:13742–13747. DOI: 10.1073/pnas.93.24.13742.
19. Stein GH, Drullinger LF, Soulard A, Dulić V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol. 1999;19:2109–2117. DOI: 10.1128/MCB.19.3.2109.
20. Hoving S, Heeneman S, Gijbels MJ, te Poele JA, Russell NS, Daemen MJ, Stewart FA. Single-dose and fractionated irradiation promote initiation and progression of atherosclerosis and induce an inflammatory Downloaded from http://ahajournals.org by on July 6, 2021 J Am Heart Assoc. 2021;0:e020712. DOI: 10.1161/JAHA.120.020712 11 Yamamoto et al Radiation-Induced Atherosclerosis Via Senescence plaque phenotype in ApoE(-/-) mice. Int J Radiat Oncol Biol Phys. 2008;71:848–857. DOI: 10.1016/j.ijrobp.2008.02.031.
21. Stewart FA, Heeneman S, Te Poele J, Kruse J, Russell NS, Gijbels M, Daemen M. Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage. Am J Pathol. 2006;168:649– 658. DOI: 10.2353/ajpath.2006.050409.
22. Singh VK, Seed TM. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures. Int J Radiat Biol. 2017;93:851–869. DOI: 10.1080/09553 002.2017.1332438.
23. Booth C, Tudor G, Tudor J, Katz BP, MacVittie TJ. Acute gastrointestinal syndrome in high-dose irradiated mice. Health Phys. 2012;103:383– 399. DOI: 10.1097/HP.0b013e318266ee13.
24. Koch A, Gulani J, King G, Hieber K, Chappell M, Ossetrova N. Establishment of early endpoints in mouse total-body irradiation model. PLoS One. 2016;11:e0161079. DOI: 10.1371/journal.pone.0161079.
25. Le ON, Rodier F, Fontaine F, Coppe JP, Campisi J, DeGregori J, Laverdière C, Kokta V, Haddad E, Beauséjour CM. Ionizing radiationinduced long-term expression of senescence markers in mice is independent of p53 and immune status. Aging Cell. 2010;9:398–409. DOI: 10.1111/j.1474-9726.2010.00567.x.
26. Milliat F, François A, Isoir M, Deutsch E, Tamarat R, Tarlet G, Atfi A, Validire P, Bourhis J, Sabourin J-C, et al. Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: implication in radiation-induced vascular damages. Am J Pathol. 2006;169:1484– 1495. DOI: 10.2353/ajpath.2006.060116.
27. Bentzon JF, Sondergaard CS, Kassem M, Falk E. Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice. Circulation. 2007;116:2053–2061. DOI: 10.1161/CIRCULATIONAHA.107.722355.
28. Daniel JM, Bielenberg W, Stieger P, Weinert S, Tillmanns H, Sedding DG. Time-course analysis on the differentiation of bone marrow-derived progenitor cells into smooth muscle cells during neointima formation. Arterioscler Thromb Vasc Biol. 2010;30:1890–1896. DOI: 10.1161/ ATVBAHA.110.209692.
29. Nelson G, Wordsworth J, Wang C, Jurk D, Lawless C, MartinRuiz C, von Zglinicki T. A senescent cell bystander effect: senescence-induced senescence. Aging Cell. 2012;11:345–349. DOI: 10.1111/j.1474-9726.2012.00795.x.
30. Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, Athineos D, Kang T-W, Lasitschka F, Andrulis M, et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol. 2013;15:978–990. DOI: 10.1038/ncb2784.
31. Song Y, Shen H, Schenten D, Shan P, Lee PJ, Goldstein DR. Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2012;32:103–109. DOI: 10.1161/ATVBAHA.111.236349.
32. Gardner SE, Humphry M, Bennett MR, Clarke MC. Senescent vascular smooth muscle cells drive inflammation through an interleukin-1αdependent senescence-associated secretory phenotype. Arterioscler Thromb Vasc Biol. 2015;35:1963–1974. DOI: 10.1161/ATVBA HA.115.305896.
33. Wang J, Uryga AK, Reinhold J, Figg N, Baker L, Finigan A, Gray K, Kumar S, Clarke M, Bennett M. Vascular smooth muscle cell senescence promotes atherosclerosis and features of plaque vulnerability. Circulation. 2015;132:1909–1919. DOI: 10.1161/CIRCULATIO NAHA.115.016457.
34. Sano N, Satow T, Maruyama D, Kataoka H, Morita K, Ishibashi-Ueda H, Iihara K. Relationship between histologic features and outcomes of carotid revascularization for radiation-induced stenosis. J Vasc Surg. 2015;62:370–377.e371. DOI: 10.1016/j.jvs.2015.03.021.
35. Wang Y, Schulte BA, LaRue AC, Ogawa M, Zhou D. Total body irradiation selectively induces murine hematopoietic stem cell senescence. Blood. 2006;107:358–366. DOI: 10.1182/blood-2005-04-1418.
36. Xie M, Lu C, Wang J, McLellan MD, Johnson KJ, Wendl MC, McMichael JF, Schmidt HK, Yellapantula V, Miller CA, et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med. 2014;20:1472–1478. DOI: 10.1038/nm.3733.
37. Libby P, Ebert BL. CHIP (clonal hematopoiesis of indeterminate potential): potent and newly recognized contributor to cardiovascular risk. Circulation. 2018;138:666–668. DOI: 10.1161/CIRCULATIO NAHA.118.034392.
38. Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, McConkey M, Gupta N, Gabriel S, Ardissino D, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377:111–121. DOI: 10.1056/NEJMoa1701719.